ICD-10-CM Billable Code

M05.0

Felty's syndrome

Clinical Classification Guidelines

Inclusion Terms

  • Rheumatoid arthritis with splenoadenomegaly and leukopenia

Medical Intelligence & Overview

Felty's syndrome is a rare complication of rheumatoid arthritis characterized by an enlarged spleen (splenomegaly) and a decreased number of white blood cells (leukopenia). It primarily affects individuals with long-standing rheumatoid arthritis and can lead to increased susceptibility to infections. Recognized by its combination of rheumatoid joint symptoms and systemic signs, Felty's syndrome requires careful medical management to prevent serious complications.

Causes & Symptoms

Clinical Causes: Felty's syndrome most often develops in patients with a history of chronic rheumatoid arthritis. While the exact cause isn't fully understood, several factors are associated with its development: - Long-standing rheumatoid arthritis, especially when the disease has been active for many years - Immune system abnormalities that lead to destruction of white blood cells - Genetic predispositions that influence immune responses - Potentially, environmental triggers that may exacerbate autoimmune activity The syndrome appears to result from an abnormal immune response that damages blood cells and enlarges the spleen, further impairing immune function.

Key Symptoms: Individuals with Felty's syndrome may experience a variety of symptoms, including: - Symptoms of rheumatoid arthritis such as joint pain, swelling, and stiffness - Enlarged spleen causing a feeling of fullness or discomfort in the upper left abdomen - Increased susceptibility to infections due to low white blood cell counts - Fatigue and weakness - Unexplained fevers - Anemia, which can cause pallor and weakness - Bleeding tendencies or easy bruising, related to decreased blood component production Since symptoms can vary, some patients may present predominantly with infection-related problems, while others mainly report joint issues.

Diagnostic & Treatment

Diagnosis Path: Diagnosing Felty's syndrome involves a combination of clinical evaluation and laboratory tests: - Medical history, focusing on rheumatoid arthritis duration and symptoms - Physical examination, noting splenomegaly and joint inflammation - Blood tests that typically reveal: - Leukopenia (low white blood cell count) - Anemia - Thrombocytopenia (low platelet count in some cases) - Imaging studies such as ultrasound or CT scans to assess spleen size - Rheumatoid factor and anti-CCP antibodies to confirm persistent rheumatoid arthritis Early diagnosis is crucial to manage potential complications effectively.

Treatment Protocols: While there is no specific cure for Felty's syndrome, various treatment strategies aim to control symptoms and prevent infections: - Management of rheumatoid arthritis with disease-modifying antirheumatic drugs (DMARDs) - Use of corticosteroids to reduce inflammation and immune activity - Antibiotics and antiviral medications to treat or prevent infections - Growth factors like G-CSF (granulocyte colony-stimulating factor) to boost white blood cell counts in certain cases - Splenectomy (removal of the spleen) may be considered when enlarged spleen causes significant symptoms or recurrent infections - Supportive care includes regular monitoring of blood counts and infection prevention measures Treatment plans are tailored to each patient's condition and response, with close coordination between rheumatologists and hematologists.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is M05.0 a billable ICD-10 code?
Yes, M05.0 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report M05.0?
Clinical documentation must specify the nature of Felty's syndrome and any associated comorbidities for accurate reporting.

Cite this Clinical Reference